Bernardini C, Del Tacca M, Danesi R, Della Torre P
Arch Int Pharmacodyn Ther. 1986 Oct;283(2):243-53.
The influence of amrinone (AM), a positive inotropic drug, on cardiotoxicity induced by repeated adriamycin (ADR) administration, was studied in rats. AM, administered at various doses, did not affect rat body weight gain, heart rate, electrocardiographic parameters (QRS complex, S alpha T segment, T-wave), or the histological cardiac picture. By contrast, ADR markedly inhibited rat body weight increase and induced the appearance of early ECG alterations, especially S alpha T widening, as well as morphological cardiac changes consisting of macrovacuolation of myocytes, atrophy, necrosis and fibrosis. When given with ADR, AM reduced the toxicity of ADR limiting the deleterious effects of the drug on body weight gain and delaying the appearance of ECG abnormalities, particularly S alpha T widening and T-wave flattening. The severity of cardiac lesions histologically evaluated at the end of the experiment, however, was similar in rats given ADR or AM plus ADR. These results may be explained by taking into account the ability of AM to increase the Ca2+ influx through the slow channels in myocardial cells, thus counteracting the decreased inward slow Ca2+ currents due to ADR. The failure of AM to improve histological cardiac alterations significantly, seems to indicate that among the numerous pathogenetic mechanisms of ADR-induced cardiotoxicity, the changes in cellular Ca2+ fluxes play an important, but not a fundamental role.
在大鼠中研究了正性肌力药物氨力农(AM)对反复给予阿霉素(ADR)所致心脏毒性的影响。给予不同剂量的AM,对大鼠体重增加、心率、心电图参数(QRS波群、SαT段、T波)或心脏组织学表现均无影响。相比之下,ADR显著抑制大鼠体重增加,并导致早期心电图改变,尤其是SαT段增宽,以及心脏形态学改变,包括心肌细胞大空泡形成、萎缩、坏死和纤维化。当与ADR合用时,AM降低了ADR的毒性,限制了该药物对体重增加的有害影响,并延迟了心电图异常的出现,尤其是SαT段增宽和T波低平。然而,在实验结束时组织学评估的心脏病变严重程度,在给予ADR或AM加ADR的大鼠中相似。这些结果可以通过考虑AM增加心肌细胞通过慢通道的Ca2+内流的能力来解释,从而抵消由于ADR导致的内向慢Ca2+电流减少。AM未能显著改善心脏组织学改变,似乎表明在ADR诱导心脏毒性的众多发病机制中,细胞Ca2+通量的变化起重要作用,但不是根本作用。